To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

NCT02220972 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Epilepsy, Partial

Interventions

DRUG: Perampanel
DRUG: Placebo

Sponsor

Eisai Inc.